Characteristic (n) | Category | n (%) |
---|---|---|
Sex (154) | Male | 150 (97.4) |
Female | 4 (2.6) | |
Race (154) | White | 142 (92.2) |
Black | 6 (3.9) | |
Other | 6 (3.9) | |
Duration of PPI use (156) | 0–2 months | 48 (30.8) |
2 months to 2 years | 34 (21.8) | |
3–5 years | 20 (12.8) | |
> 5 years | 54 (34.6) | |
Name of current PPI (156) | Omeprazole | 92 (58.9) |
Pantoprazole | 58 (37.2) | |
Lansoprazole | 4 (2.6) | |
Esomeprazole | 2 (1.3) | |
Interval of PPI (156) | Once a day | 103 (66) |
Twice a day | 52 (33.3) | |
As needed | 1 (0.6) | |
Route of PPI (156) | Oral | 154 (98.7) |
Intravenous | 2 (1.3) | |
Medical provider who initiated the PPI (156) | Primary care physician | 91 (58.3) |
Internal medicine | 47 (30.1) | |
Surgery | 11 (7.1) | |
Gastroenterology | 7 (4.5) | |
Setting where the PPI was started (156) | Outpatient | 98 (62.8) |
Non-ICU | 53 (34) | |
ICU | 5 (3.2) |